baber/WOPTO huggingface dataset:
Patent AU-2007227170-B2 (AU)
Title: Modular fracture fixation plate system
Inventor: MEBARAK EDWARD
IPC: A61F2/30
Filed: 2007-03-07
Granted: 2013-10-17
Abstract: A fracture fixation plate system for use on a long bone having a metaphysis and a diaphysis, includes at least one end plate having a head portion for the metaphysis, and at least one fragment plate having a first end and a second end with a plurality of screw holes therebetween. The end plate includes mating structure adapted to mate with and securely couple to at least one end of the at least one fragment plate. The system preferably includes several end plates and fragment plates to accommodate anatomy of various sizes.
Patent AU-2007229443-B2 (AU)
Title: Polygonal overhead cable
Inventor: KIKUCHI NAOSHI
IPC: D07B1/10
Filed: 2007-10-23
Granted: 2013-01-10
Abstract: An overhead cable including a plurality of element wires stranded to form a naked stranded cable, which has a cross-sectional shape of an equilateral polygon 5 inscribed in a circle having a diameter of 18.2 mm to 38.4 mm as a fundamental cross-sectional shape, in which two sides of this equilateral polygon that are located at positions farthest from each other are outwardly projected, has two flat-plate-shaped 10 projections corresponding to the two sides, wherein the number of angles of the equilateral polygon is 16 when the diameter of the circle is 18.2 mm, the number of angles is 17 when the diameter is 22 mm, the number of angles is 20 when the diameter is 24.4 mm, the number 15 of angles is 20 or 21 when the diameter is 27.4 mm, the number of angles is 22 when the diameter is 32.6 mm, and the number of angles is 22 when the diameter is 38.4 mm, and a height of the flat-plate-shaped projections is equal to or larger than 0.3 mm and equal 20 to or smaller than 0.75 mm. 3 0.m3 F IG. 1A F18.G.1 32 6 3a 32 3 0.5mm 0.5mm 6 3a 282mm 282mm F I G. 2A F I G. 2B 3 3a 3a .m 246 0.4mm FIG.3A FIG.3B
Patent AU-2007236170-B2 (AU)
Title: Multi-layer body with volume hologram
Inventor: STAUB RENE
IPC: G03H1/20
Filed: 2007-04-05
Granted: 2012-04-05
Abstract: Described is a method for producing a multi-layer body having a volume hologram with at least two different image information items, wherein a photosensitive layer (46) of the multi-layer body is brought into contact with the front side of a master (44) directly or by interposing a transparent optical medium (44s, 45), into which front side nested areas with different asymmetrical surface structures or kinoform structures are formed which embody the at least two different image information items. The photosensitive layer (46) and the master are exposed using a coherent light beam (47), by means of which a volume hologram is formed in the photosensitive layer (46). A master for producing the multi-layer body and a security element with said multi-layer body are further described.
Patent AU-2007246914-B2 (AU)
Title: A protease detection product
Inventor: DAVIS PAUL JAMES
IPC: C12Q1/37
Filed: 2007-04-05
Granted: 2013-03-14
Abstract: A protease detection product (1) for detecting a protease enzyme in a sample. The protease detection product (1) comprises a medium (2) providing a liquid flow path; a labelled component (6) located on the liquid flow path; a capture component (12) located downstream of the labelled component (6) and immobilisation means (8) for immobilising the intact labelled component. The labelled component (7) comprises a base element (8) connected to releasable element via a protease-sensitive linker peptide (9). The releasable element comprises a label (10). The capture component (12) is capable of binding the releasable element.
Patent AU-2007247218-B2 (AU)
Title: Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
Inventor: EICKELMANN PETER
IPC: C07D309/10
Filed: 2007-05-02
Granted: 2012-12-06
Abstract: Glucopyranosyl- substituted, benzonitrile derivatives defined according to formula I, including the tautomers, the stereoisomers thereof, the mixtures thereof and the salts thereof . The compounds according to the invention are suitable for the treatment of metabolic disorders. formula (I), wherein Rdenotes hydrogen, fluorine, chlorine, bromine, iodine, methyl, ethyl, propyl, \ isopropyl, butyl, sec-butyl, iso-butyl, tert-butyl, 3-methyl-but-1-yl, cyclopropyl, \ cyclobutyl, cyclopentyl, cyclohexyl, 1-hydroxy-cyclopropyl, 1-hydroxy-cyclobutyl, 1- hydroxy-cyclopentyl, 1 -hydroxy-cyclohexyl, difluoromethyl, trifluoromethyl, pentafluoroethyl,_2-hydroxyl-ethyl, hydroxymethyl, 3-hydroxy-propyl, 2-hydroxy-2- methyl-prop-1-yl, 3-hydroxy-3-methyl-but-1-yl, 1-hydroxy-1 -methyl-ethyl, 2,2,2- trifluoro-1-hydroxy-1 -methyl-ethyl, 2,2,2-trifluoro-i-hydroxy-i-trifluoromethyl-ethyl, 2- methoxy-ethyl, 2-ethoxy-ethyl, hydroxy, difiuoromethyloxy, trifluoromethyloxy, 2- methyloxy-ethyloxy, methylsulfanyl, methylsulfinyl, methlysulfonyl, ethylsulfinyl, ethylsulfonyl, trimethylsilyl or cyano,
Patent AU-2007269104-B2 (AU)
Title: Surgical tools for LVAD implantation
Inventor: COHN WILLIAM E
IPC: A61F2/00
Filed: 2007-07-03
Granted: 2012-10-18
Abstract: Novel tools for surgery are described herein. The disclosed devices incorporate novel features which enable a surgeon to perform artificial device (, left ventricular assist devices (LVAD)) implantations and other procedures more efficiently and easily. One embodiment of an apparatus employs a suction element that is adapted to releasably couple to a surgical connector. The suction element simultaneously positions and stabilizes the organ and the surgical connector to the organ. In an embodiment of another device, a coring system employs a balloon catheter and a coring tool which is adapted to be threaded on to a guide wire. Embodiments of the coring tool ensure removal and excision of cored tissue while preventing blood loss. In an embodiment of yet another device, an automated surgical connector employs a novel press-fit mechanism. The press-fit mechanism allows a surgeon to attach the connector to an organ without the use of sutures.
Patent AU-2007284136-B2 (AU)
Title: Insertion system for implanting a medical device and surgical methods
Inventor: PROCH FRANCIS S
IPC: A61B17/68
Filed: 2007-08-06
Granted: 2012-07-05
Abstract: The present invention relates to an insertion system for medical devices and to surgical methods for the implantation of the same. In one embodiment, the implantation system includes a guide wire and an insertion tool. The insertion tool includes a longitudinal bore extending therethrough for receipt of the guide wire. A portion of the longitudinal bore of the insertion tool mates with the outer surface of the guide wire to rotationally lock the insertion tool and the guide wire. Additionally, the medical device to be inserted includes a longitudinal bore for receipt of the guide wire. Similarly, at least a portion of the longitudinal bore of the medical device may also mate with the outer surface of the guide wire to rotationally lock the medical device and the guide wire. The rotational locks allow for rotation of the insertion tool to result in corresponding rotation of the medical device via rotation of the guide wire. In another embodiment, the insertion system further includes a needle having an eyelet for receiving and positioning filaments attached to the medical device.
Patent AU-2007294700-B2 (AU)
Title: Suspended cable support system
Inventor: JETTE ROGER
IPC: E04C2/52
Filed: 2007-09-14
Granted: 2013-11-07
Abstract: According to an aspect of the present disclosure, a suspended cable support system is provided. The suspended cable support system includes a plurality of suspension rods; and at least one cable tray. Each cable tray includes a pair of stringer elements, wherein each stringer element is configured for connection to at least one suspension rod; and a channel section depending from the pair of stringer elements. The channel section defines a passageway for supporting runs of cable thereon. The channel section includes a plurality of riser portions connected to the pair of stringer elements.
Patent AU-2007303059-B2 (AU)
Title: Secure multi-channel authentication
Inventor: GREENBERG ADAM
IPC: G06F21/40
Filed: 2007-10-05
Granted: 2014-01-30
Abstract: The techniques describe methods and apparatus, including computer programs products for using multiple channels to enable a user to access a resource. A first authentication parameter from a first device is received over a first channel and a token value and a second authentication parameter are received over a second channel. The token value is used to associate the first authentication parameter and the second authentication parameter. Enabling or disabling the access of the user is based on the association of the first authentication parameter and the second authentication parameter.
Patent AU-2008226443-B2 (AU)
Title: Preparation and use of plant embryo explants for transformation
Inventor: LUDWIG CINDY L
IPC: C12N15/82
Filed: 2008-03-10
Granted: 2013-07-11
Abstract: The present invention relates to excision of explant material comprising meristematic tissue from seeds, and storage of such material prior to subsequent use in plant tissue culture and genetic transformation. Methods for tissue preparation, storage, and transformation are disclosed, as is transformable meristem tissue produced by such methods, and apparati for tissue preparation.
Patent AU-2008295788-B2 (AU)
Title: Mutants having capability to produce 1,4-butanediol and method for preparing 1,4-butanediol using the same
Inventor: PARK SI JAE
IPC: C12N15/10
Filed: 2008-08-13
Granted: 2013-01-17
Abstract: A mutant capable of producing 1,4-butanediol and a method of preparing 1,4- butanediol using the same are provided. The mutant microorganism is prepared by introducing and amplifying genes encoding enzymes converting succinate into 4- hydroxybutyrate and 4-hydroxybutyrate into 1,4-butanediol in a microorganism capable of producing succinate. The method includes culturing the mutant in a medium containing carbohydrate and obtaining 1,4-butanediol from the culture. Thus, 1,4-butanediol, which is essential in chemical industry, can be prepared in a biological process.
Patent AU-2008309486-B2 (AU)
Title: Contact lens
Inventor: PERRIN GERARD
IPC: G02C7/04
Filed: 2008-07-28
Granted: 2014-06-19
Abstract: The invention relates to a contact lens having at least two focal lengths, a single lower supporting element (1) enabling the lens to be moved in translation in relation to the eye and a region (9) in the lower part of the lens, which region (9) has an outer face connected to the rest of the outer face (E) of the lens by means of a recess and an inner face merging with the rest of the inner face (i) of the lens, said recess defining the lower supporting element (1). The lens is characterised in that the aforementioned region (9) is thin, having an average thickness (e4) of the same order of magnitude as the thickness (e1) of the upper edge (3) of the lens.
Patent AU-2008311114-B2 (AU)
Title: Liquid optics zoom lens and imaging apparatus
Inventor: NEIL IAIN A
IPC: G02B3/14
Filed: 2008-09-19
Granted: 2013-09-26
Abstract: A high performance zoom lens system suitable for use with a camera is disclosed. The zoom lens systems employs liquid optics (LC) and a movable lens group (G2) to provide optical performance over the zoom focal length range at focus distances from close to infinity. The system also provides compensation for undesirable thermally induced effects by adjustments of the zoom group and the variably shaped optical surface in the liquid lens cell (LC).
Patent AU-2008313425-B2 (AU)
Title: Improved process for preparing 2-(substituted phenyl)-2-hydroxy-ethyl carbamates
Inventor: MEIER THOMAS
IPC: C07C33/46
Filed: 2008-10-18
Granted: 2013-09-26
Abstract: The present invention relates to a process of preparing a compound of Formula I: (I) Formula I Wherein R
Patent AU-2008313616-B2 (AU)
Title: Novel method for the synthesis of anticancer (poly)aminoalkylaminoacetamide derivatives of epipodophyllotoxin
Inventor: GUMINSKI YVES
IPC: C07D493/04
Filed: 2008-09-23
Granted: 2012-01-19
Abstract: The invention relates to a novel method for preparing (poly)aminoalkylaminoacetamide compounds of epipodophyllotoxin, which can be used in therapeutics as anticancer agents. The invention includes a step comprising the condensation of a primary amine reactant, the amine functions of which are not protected, with 4β-chloroacetamido-4'-epipodophyllotoxin in an aprotic polar organic solvent.
Patent AU-2008324207-B2 (AU)
Title: Photovoltaic device
Inventor: SLAGER BEN
IPC: G02B5/04
Filed: 2008-11-05
Granted: 2013-09-12
Abstract: A photovoltaic device comprising at least one active layer and a transparent cover plate which contains on at least one side an array of geometrical optical relief structures and which is in optical contact with a surface receiving side of the at least one active layer of a photovoltaic device, characterized in that the optical relief structures comprise a base and a single apex which are connected by at least three n-polygonal surfaces where n is equal to 4 or higher.
Patent AU-2008328754-B2 (AU)
Title: Novel tissue protective erythropoietin receptor (NEPOR) and methods of use
Inventor: BROCK STEPHAN
IPC: C12Q1/68
Filed: 2008-11-28
Granted: 2015-04-16
Abstract: There is disclosed a molecular composition(s) of a novel tissue protective erythropoietin (EPO) binding receptor protein complex, termed NEPOR. Presence of NEPOR components on a tumour allows EPO to impinge on the survival of associated cells thereby enhancing tumour progression and negatively effecting patient survival. There is disclosed that presence of NEPOR represents a prognostic biomarker for poorer patient outcome. Thus, the method disclosed is for stratifying patients having a tumour as suitable (i.e. NEPOR not present) or non-suitable (i.e., NEPOR present) for EPO treatment, comprising: (a) isolating a tissue sample from an individual who is receiving or is a candidate for receiving erythropoietin, (b) determining the level of expression of the NEPOR gene(s) (mRNA) and/or the presence of the NEPOR gene product (protein) from the isolated tissue, and (c) correlating the presence of an NEPOR gene expression product or the presence of NEPOR protein to a physiological response to the treatment with erythropoietin. Furthermore, by disclosing the molecular compositions of NEPOR species, there are disclosed methods for rationally identifying/designing NEPOR modulating therapeutics. Thus, the present disclosure provides methods for treating neurological insults such as stroke (via enhancement of NEPOR activity) and cancer (via down-regulation of cyto-protective signaling from NEPOR).
Patent AU-2009201761-B2 (AU)
Title: Surgical instrument with clamp
Inventor: FARASCIONI DAVID
IPC: A61B17/03
Filed: 2009-05-04
Granted: 2014-07-03
Abstract: SURGICAL INSTRUMENT WITH CLAMP A surgical instrument (100) for surgically joining tissue is disclosed. The surgical instrument (100) includes a handle portion, an endoscopic portion (110), a pair of s jaw members (220) and a clamp (230). The endoscopic portion (110) extends distally from the handle portion and defines a first longitudinal axis. The pair of jaw members (220) is disposed adjacent a distal end of the endoscopic portion (110) and extends generally distally therefrom. At least one of the jaw members (220) is movable with respect to the other between an open position and an approximated position for engaging io body tissue therebetween. The clamp (230) is disposed adjacent the jaw members (220) and extends generally distally from the endoscopic portion (110). The clamp (230) is movable between an open position and an approximated position for engaging body tissue. The clamp (230) is independently movable with respect to the jaw members (220). c=1~
Patent AU-2009216008-B2 (AU)
Title: Apparatus and method for encoding and decoding channel in a communication system using low-density parity-check codes
Inventor: KIM KYUNG-JOONG
IPC: H03M13/00
Filed: 2009-02-18
Granted: 2013-07-25
Abstract: An apparatus and method for generating a parity-check matrix of a Low-Density Parity-Check (LDPC) code are provided. Parameters for designing the LDPC code are determined, and a first parity-check matrix of a quasi-cyclic LDPC code is formed according to the determined parameters. A second parity-check matrix is created through the elimination of a predetermined portion of a parity part in the first parity-check matrix, and a third parity-check matrix is created by rearranging the second parity-check matrix.
Patent AU-2009222584-B2 (AU)
Title: Authentication and authorization architecture for an access gateway
Inventor: D ANGELO GIOVANNI
IPC: H04L29/06
Filed: 2009-10-02
Granted: 2012-06-14
Abstract: 10/2009 Fri 17:11 Callinans +613 98097565 ID: #42260 Page 67 of 89 ABsTRAcT A telecommunications architecture exposes telecommunications services to third parties through a secure access gateway. The third parties s may be other telecommunications service providers who employ the services to support their own products and services. The access gateway provides a secure, standardized, and controlled access platform for the exposed services, and addresses the technical problems associated with such access. In addition to providing technical solutions for efficient and secure access to 10 exposed services, the architecture also provides an additional revenue channel for existing telecommunication service providers. COMS ID No: ARCS-251528 Received by IP Australia: Time (H:m) 17:50 Date (Y-M-d) 2009-10-02 M0/2009 Fri 17:1 Callinans +613 98097565 ID: #42260 Page 68 of 89 r- ----------- - - - - - - - - -- -- - -IThird Parties DevIces Applications 10 Others 108 --------------------------------------------- ------ r ---------------------------------- L- -- -- -- -- -- --------------------------- r ----------------------------------- -- Third Party Acces Gateway BSS/OSS 12 Service Broer Netwrk Layer .2 ---------------------------- I Figure 1 COMS ID No: ARCS-251528 Received by IP Australia: Time (H:m) 17:50 Date (Y-M-d) 2009-10-02
Patent AU-2009223653-B2 (AU)
Title: Methods and compositions for controlled delivery of phytochemical agents
Inventor: VADHANAM MANICKA V
IPC: A61K35/12
Filed: 2009-03-10
Granted: 2014-07-31
Abstract: The presently-disclosed subject matter provides compositions and methods for treating a cancer by providing a composition comprising a biocompatible polymeric matrix incorporating an effective amount of a phytochemical agent, a combination of phytochemical agents, or a phytochemical agent and a chemotherapeutic agent. Further, provided is a device for uterine cervical insertion for local delivery.
Patent AU-2009224968-B2 (AU)
Title: Long-term stable pharmaceutical preparation having the active ingredient glycerol trinitrate
Inventor: UECK HENNING
IPC: A61K9/12
Filed: 2009-03-12
Granted: 2014-01-16
Abstract: The invention relates to a pharmaceutical composition containing the active ingredient glycerol trinitrate having improved storage stability in a container. The improved storage stability is achieved by adding a substance absorbing protons, which is added to the composition, or applied to the surfaces of the container coming in contact with the product. The composition is preferably filled into a plastic bottle having a spray pump.
Patent AU-2009231582-B2 (AU)
Title: Amplicon rescue multiplex polymerase chain reaction for amplificaton of multiple targets
Inventor: HAN JIAN
IPC: C12P19/34
Filed: 2009-04-03
Granted: 2015-02-26
Abstract: Disclosed is a method for amplifying and detecting polynucleotides which can provide sensitive, specific detection of multiple targets from a clinical specimen within a relatively short time.
Patent AU-2009238276-B2 (AU)
Title: System and method for improved client server communications of email messages
Inventor: NOVITSKEY ROBERT R
IPC: G06F13/00
Filed: 2009-11-13
Granted: 2011-11-10
Abstract: L VM 22/059 A system and method for improved client and server communications, more particularly, an improved protocol that may be used for communication between a client and a server, such as in an email environment. Many features are provided for improved communications. An email server may provide the best message body available for an email message, may transfer an entire data object if requested property or properties are not well defined within the data object, may provide progress data for use in tracking download progress, and may send error information for a data object having an error. Email changes may be optimized at an email server component, even if the email changes occurred at another email server component. An email server may maintain a table of changes that occur to folders at an associated data store, and may notify a subscribed email client component of changes that occur in the table. 220635app Email Email Client Server Component Component N/4 Protocols 302 V2 V2 305 -- 309 - 308 303 Vn Vn 306
Patent AU-2009241365-B2 (AU)
Title: Compositions and methods for treating multiple sclerosis
Inventor: WATSON RICHARD L
IPC: C12N5/071
Filed: 2009-04-27
Granted: 2015-01-22
Abstract: Provided are electrokinetically-altered fluids (gas-enriched electrokinetic fluids) comprising an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an amount sufficient to provide modulation of at least one of cellular membrane potential and cellular membrane conductivity, and therapeutic compositions and methods for use in treating inflammatory neurodegenerative condition or disease or at least one symptom thereof. The electrokinetically-altered fluids or therapeutic compositions and methods include electrokinetically-altered ioinic aqueous fluids optionally in combination with other therapeutic agents. Particular aspects provide for regulating or modulating intracellular signal transduction associated with said inflammatory responses by modulation of at least one of cellular membranes, membrane potential, membrane proteins such as membrane receptors, including but not limited to G-Protein Coupled Receptors (GPCR), and intercellular junctions (e.g., tight junctions, gap junctions, zona adherins and desmasomes). Other embodiments include particular routes of administration or formulations for the electrokinetically-altered fluids (e.g., electrokinetically-altered gas-enriched fluids and solutions) and therapeutic compositions.
Patent AU-2009266360-B2 (AU)
Title: Extended messaging platform
Inventor: ANTHONY UNDERWOOD JOHN
IPC: H04L69/40
Filed: 2009-06-30
Granted: 2011-09-15
Abstract: A message system, including at least one server configured to receive a message from a originating device for delivery to at least one recipient device via a first delivery channel; and wherein the at least one server is further configured to select an alternate delivery channel in the event that delivery of the message via the first delivery channel cannot be effected, is disclosed. The invention further discloses a method for routing messages including the steps of receiving at a server a message from an originating device for delivery to a to at least one recipient; forwarding the message to the at least one recipient device via a first delivery channel; awaiting receipt of acknowledgement message from said least one recipient device, and in the event that no acknowledgment message is received, the at least one server resends the message to said at least one recipient device via an alternate delivery channel.
Patent AU-2009272654-B2 (AU)
Title: Enzymatical modif ication of cell glycosylation using serum albumin and divalent cations
Inventor: NYSTEDT JOHANNA
IPC: C12N5/071
Filed: 2009-07-16
Granted: 2015-01-15
Abstract: The invention is directed to a method and kit to control and modify the status of cells, such as human stem cells, by changing their glycosylation, in particular sialylation and fucosylation, levels in a reaction condition where culture medium reagents, such as divalent cations, are present and cells are kept non-adherent. The invention is further directed to novel stem cells, the glycosylation of which has been specifically altered.